Related Experiment Video
Updated: Jun 16, 2026

08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Paraquat and Parkinson's disease
C Berry1, C La Vecchia, P Nicotera
1Queen Mary, University of London, London, E1 4NS, UK.
Cell Death and Differentiation
|January 23, 2010
Summary
Environmental chemicals like paraquat (PQ) are debated in Parkinson's disease (PD) development. While PQ causes parkinsonism in rodents, human evidence linking PQ exposure to increased PD risk remains limited.
Area of Science:
- Environmental health
- Neuroscience
- Toxicology
Background:
- Parkinson's disease (PD) pathogenesis is increasingly linked to complex genetic alterations.
- The role of environmental chemicals in PD development is a significant area of research and debate.
- Acute exposure to certain neurotoxins, like MPTP, can induce parkinsonism, but environmental risk factors are less clear.
Purpose of the Study:
- To critically analyze the evidence implicating the pesticide paraquat (PQ) in the development of Parkinson's disease.
- To evaluate the limitations of using chemical exposure models for studying PD pathogenesis.
- To assess the strength of epidemiological data connecting environmental factors to PD risk.
Main Methods:
- Literature review of epidemiological studies on pesticide exposure and PD.
- Analysis of experimental research on paraquat (PQ) effects in animal models.
- Critical evaluation of the evidence linking paraquat exposure to human parkinsonism.
Main Results:
- Pesticide exposure, including paraquat (PQ), has been suggested as a risk factor for PD.
- Rodent studies show PQ can induce lesions in the substantia nigra, a hallmark of PD.
- Epidemiological data directly linking human paraquat exposure to an increased risk of PD is limited and often insufficient.
Conclusions:
- While paraquat (PQ) shows neurotoxic effects in experimental models, robust evidence for its role in increasing human PD risk is currently lacking.
- The limitations of current epidemiological data highlight the challenges in definitively establishing environmental chemicals as causes of PD.
- Further research is needed to clarify the complex interplay between environmental exposures and genetic factors in Parkinson's disease etiology.
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
